Search clinical trials for: Hydroxychloroquine Sulfate Azythromycin

Total 3889 results

Apsen Farmaceutica S.A.
Federal University of São Paulo

Withdrawn

Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Coronavirus Infections | SARS-CoV 2 | Pulmonary Disease | SARS (Severe Acute Respiratory Syndrome)

Brazil
Institute for Research and Development of Medicinal...

Unknown

Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients (PHYTCOVID-19)

Covid19

Guinea
Institute for Research and Development of Medicinal...

Unknown

Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients (CANCOVID-19)

Covid19

Guinea
Rutgers, The State University of New Jersey

Terminated

Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19

COVID-19 | SARS-CoV-2

United States
Azidus Brasil

Suspended

Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19

COVID-19

Brazil
Azidus Brasil

Suspended

Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19

Covid-19

Brazil
Rutgers, The State University of New Jersey

Withdrawn

Asymptomatic COVID-19 Trial (ACT)

SARS-CoV-2 Infection

United States
Alkarkh Health Directorate-Baghdad

Completed

Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients

IMMUNOTHERAPY

Iraq
National Institute of Allergy and Infectious Diseases...
Teva Pharmaceutical Industries, Ltd.

Terminated

Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19

COVID-19 | SARS-CoV 2

United States
University Hospital, Montpellier

Terminated

Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial) (COVIDOC)

Coronavirus Infection | Pneumonia, Viral

France
Assistance Publique - Hôpitaux de Paris

Completed

Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus (PREP-COVID)

SARS-CoV-2 Infection

France
Hospital do Coracao
Hospital Israelita Albert Einstein; Hospital Sirio-Libanes; Brazilian Research... and other collaborators

Completed

Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19) (Coalition-I)

Coronavirus Infections

Brazil
Institut de cancérologie Strasbourg Europe

Withdrawn

Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE) (HYACINTHE)

Hematologic Malignancy | COVID19

France
Children's Hospital of Fudan University

Recruiting

Hydroxychloroquin (HCQ) in chILD of Genetic Defect

Surfactant Dysfunction

China
Burnasyan Federal Medical Biophysical Center

Completed

A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19

Pneumonia, Viral | Respiratory Failure

Russian Federation
Ravi Amaravadi, MD

Terminated

The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) (PATCH)

COVID-19

United States
Health Institutes of Turkey

Completed

Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment

Covid19

Turkey
The University of Texas Medical Branch, Galveston

Recruiting

Treatment of ppROM With Erythromycin vs. Azithromycin Trial (TREAT)

Preterm Premature Rupture of Membranes (PPROM)

United States
Coordinación de Investigación en Salud, Mexico
Ultra Laboratorios SA. de CV.

Recruiting

Hidroxicloroquina With Azitromicina Versus Hidroxicloroquina and Placebo Int Patients With Mild COVID-19 (Omehecatl)

Covid19

Mexico
Assistance Publique - Hôpitaux de Paris

Withdrawn

Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients (MG-COVID)

Covid-19
Washington University School of Medicine

Terminated

Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection (WU352)

Coronavirus Infection

United States
Iterum Therapeutics, International Limited
Waterbury Hospital

Withdrawn

Azithromycin Plus Hydroxychloroquine for COVID-19 Infection

Respiratory Tract Infection Viral

United States
Hospital Israelita Albert Einstein
Hospital do Coracao; Hospital Sirio-Libanes; Brazilian Research In Intensive... and other collaborators

Completed

Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)

Coronavirus Infections | Pneumonia, Viral

Brazil
Latin American Cooperative Oncology Group
Oncoclínicas

Withdrawn

HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19 (HOPE_BRAZIL)

Sars-CoV2

Brazil
Government of Punjab, Specialized Healthcare and...
Harvard School of Public Health (HSPH); Forman Christian College, Pakistan; Services... and other collaborators

Terminated

Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds (PEACE)

COVID-19 | Coronavirus Infection | SARS-CoV-2 | Asymptomatic Condition

Pakistan
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets

Immunosuppression | Rheumatism
Pfizer

Completed

An Open, Prospective, Randomized, Multicenter Study of the Efficacy and Safety of Intravenous Followed by Oral Azithromycin Versus Cefuroxime Alone or With Oral Erythromycin for the Treatment of Chinese Patients Who Were Hospitalized for Pneumonia

Pneumonia

China
Hospital St. Joseph, Marseille, France

Withdrawn

Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial (HASCOPT)

COVID19
Patrick Hensley

Active, not recruiting

Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer

Prostate Cancer Recurrent

United States
Government of Punjab, Specialized Healthcare and...
Services Hospital, Lahore; Mayo Hospital Lahore; Pakistan Kidney and Liver Institute

Terminated

PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds (PRECISE)

Covid-19 | Sars-CoV2 | Symptomatic Condition

Pakistan
Baqiyatallah Medical Sciences University

Completed

Chronic Bronchiolitis or Resistant Asthma?

Asthma
Upazila Health & Family Planning Officer's (UHFPO)...

Completed

A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh

COVID19 | Hydroxychloroquine | Ivermectin

Bangladesh
Ministry of Health, Turkey
Istanbul University; Ankara Training and Research Hospital; Prof. Dr. Cemil Tascıoglu... and other collaborators

Active, not recruiting

Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19

COVID-19 | Sars-CoV2

Turkey
Centre Hôpital Universitaire Farhat Hached

Unknown

Hydroxychloroquine, Azithromycin in the Treatment of Covid-19 (PACTT)

COVID-19 | SARS-CoV-2 Pneumonia

Tunisia
Sheba Medical Center

Unknown

Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to "no Treatment" in SARS CoV 2 Virus (COSTA)

COVID - 19

Israel
Afyonkarahisar Health Sciences University
NeuTec Pharma

Completed

Ivermectin for Severe COVID-19 Management

COVID-19

Turkey
University Hospital, Strasbourg, France

Withdrawn

EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA (TEACHCOVID)

Sars-CoV-2, Community-Acquired Pneumonia,COVID-19
Prof. Dr. Umar Farooq
Ayub Medical College, Abbottabad

Unknown

Effectiveness of Hydroxychloroquine in Covid-19 Patients (Covid)

COVID19

Pakistan
National Cancer Institute (NCI)

Completed

Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma

Neurofibromatosis Type 1 | Cutaneous Neurofibroma | Optic Nerve Glioma

United States
Hackensack Meridian Health

Completed

Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers

Covid19

United States
Peking University First Hospital

Completed

A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy

Hydroxychloroquine | IgA Patients

China
LLiu

Completed

Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study

Primary IgA Nephropathy

China
Assistance Publique - Hôpitaux de Paris

Withdrawn

Acute Rhabdomyolysis and Muscle Pain Associated With Mutations in the LPIN1 Gene - A Retrospective Study Describing the Safety and Efficacy of Hydroxychloroquine Sulfate Given on a Compassionate Basis to Patients Suffering From Lipin-1 Deficiency (LIPIN-1-METAB)

LIPIN1 Deficiency

France
University of California, San Francisco
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger

Chlamydia Trachomatis | Trachoma

United States, Niger
Oregon Health and Science University
Patient-Centered Outcomes Research Institute; University of Alabama at Birmingham and other collaborators

Completed

Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis

Bronchiectasis
Almaza Military Fever Hospital

Completed

Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment

Covid19

Egypt
King Hussein Cancer Center

Withdrawn

Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients (COVID19-HOPE)

COVID-19 Patients

Jordan
University Hospital Tuebingen
Universitätsklinikum Hamburg-Eppendorf; Robert Bosch Medical Center; Bernhard...

Terminated

Hydroxychloroquine for COVID-19 (COV-HCQ)

COVID-19, Hydroxychloroquine Sulfate

Germany
Texas Cardiac Arrhythmia Research Foundation

Withdrawn

Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk (PREVENT)

COVID-19
University of Florida
Metabolic Solutions Inc.

Terminated

Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis (AZI)

Gastroparesis

United States

3

Subscribe